webinar: ptc therapeutics – emflaza® landscape in 2024
Published 7 months ago • 158 plays • Length 15:51Download video MP4
Download video MP3
Similar videos
-
29:09
webinar: ptc therapeutics — emflaza® landscape in 2024
-
18:33
community webinar: ptc therapeutics' 2024 emflaza® landscape
-
45:51
webinar: a conversation with ptc therapeutics (dec 2022)
-
1:24:02
[webinar] ptc therapeutics provides regulatory update on translarna - august 2016
-
1:36
dmd: charting the path for new therapeutics and better care – webinar main trailer
-
1:27:07
product management service (pms) webinar on data migration
-
43:27
ppmd 2024 annual conference: day 2 - current approved therapies panel & discussion (pt. 2)
-
1:30:15
ppmd 2024 annual conference: day 1 - newly diagnosed & duchenne 101 discussions
-
11:21
in the pipeline: restoring dystrophin - ptc therapeutics (ataluren)
-
32:41
ppmd 2024 annual conference: day 2 - keynote - a reflection on progress and hope
-
13:20
approved therapies - ptc therapeutics
-
45:03
webinar: sarepta therapeutics - data update from momentum study, srp-5051 [mar 2024]
-
0:32
perron institute duchenne muscular dystrophy ad 2023, breaking ground, changing lives.
-
17:09
ptc therapeutics (translarna) [ppmd's 2015 connect conference]
-
1:22
espid 2024: dr. matjaz homan
-
14:51
recently reported updates - ptc therapeutics (ppmd's 2021 virtual annual conference)
-
1:53:29
ppmd 2024 annual conference: day 1 - navigating the approved therapy landscape